Results 121 to 130 of about 1,494 (190)

Prospective clinical trials of venetoclax and hypomethylating agents for relapsed BPDCN

open access: yesBlood Neoplasia
Naveen Pemmaraju   +9 more
openaire   +3 more sources

Contribution of a specific panel by flow cytometry for the differential diagnosis of plasmacytoid dendritic cell neoplasms. [PDF]

open access: yesAnn Hematol
Renosi F   +17 more
europepmc   +1 more source

Efficacy of venetoclax combined with azacitidine for advanced blastic plasmacytoid dendritic cell neoplasm: experience from two Japanese cases. [PDF]

open access: yesJ Clin Exp Hematop
Shibamiya A   +10 more
europepmc   +1 more source

Pivekimab Sunirine in Blastic Plasmacytoid Dendritic Cell Neoplasm. [PDF]

open access: yesJ Clin Oncol
Pemmaraju N   +23 more
europepmc   +1 more source

Shared Care Offers an Effective Framework for Managing Tagraxofusp Treatment in Blastic Plasmacytoid Dendritic Cell Neoplasm.

open access: yesActa Haematol
Ambinder A   +7 more
europepmc   +1 more source

PS1541 OUTCOMES OF AUTOLOGOUS AND ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION FOR BPDCN

open access: yesHemaSphere, 2019
M. Qazilbash   +10 more
openaire   +1 more source

Age- and tissue-dependent diversity of human plasmacytoid dendritic cells uncovers a cycling subset dominant in early life and cancer. [PDF]

open access: yesImmunity
Antonova AU   +10 more
europepmc   +1 more source

Pivekimab sunirine in blastic plasmacytoid dendritic cell neoplasm: assessing spatial response and unraveling resistance mechanisms. [PDF]

open access: yesHaematologica
Poussard M   +18 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy